These data further verified our results obtained in vivo that SpvB regulates the hepcidin–FPN axis in a TREM-1-dependent manner, and targeting TREM-1 may provide potential therapeutics for treating salmonellosis. This evidence concerns the gene SLC40A1 and salmonellosis.